
FDA Approves First-Ever Twice-Yearly HIV Prevention Shot
FDA approves lenacapavir, the world’s first twice-yearly shot to prevent HIV, offering new hope in the fight against the virus. The long-acting injection could revolutionize HIV prevention worldwide.
